$3.69
-0.18-4.65%
Pre-Market: 7:44 PM EDT
Comments
Loading...
Qualigen Therapeutics (QLGN) Forecast
NewsEarningsQualigen Therapeutics (QLGN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestQualigen Therapeutics (NASDAQ:QLGN) Stock Quotes, Forecast and News Summary
Qualigen Therapeutics Stock (NASDAQ: QLGN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Qualigen Therapeutics (QLGN) stock?
You can purchase shares of Qualigen Therapeutics (NASDAQ:QLGN) through any online brokerage.
Who are Qualigen Therapeutics (QLGN) competitors?
Other companies in Qualigen Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and NuCana (NASDAQ:NCNA).
What is the forecast, or price target, for Qualigen Therapeutics (QLGN) stock?
There is no analysis for Qualigen Therapeutics to provide a consensus price target.
What is the current price for Qualigen Therapeutics (QLGN)?
The stock price for Qualigen Therapeutics (NASDAQ: QLGN) is $3.69 last updated November 20, 2024 at 7:44 PM EST.
Does Qualigen Therapeutics (QLGN) pay a dividend?
There are no upcoming dividends for Qualigen Therapeutics.
When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?
Qualigen Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Qualigen Therapeutics (QLGN) going to split?
There is no upcoming split for Qualigen Therapeutics.
What sector and industry does Qualigen Therapeutics (QLGN) operate in?
Qualigen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.